These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 19026455)

  • 81. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Bactrian camel nanobody-based immunoassay for specific and sensitive detection of Cry1Fa toxin.
    Wang P; Li G; Yan J; Hu Y; Zhang C; Liu X; Wan Y
    Toxicon; 2014 Dec; 92():186-92. PubMed ID: 25448390
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Application Progress of the Single Domain Antibody in Medicine.
    Tang H; Gao Y; Han J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?
    Smolarek D; Bertrand O; Czerwinski M
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():348-58. PubMed ID: 22706121
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antigen binding and solubility effects upon the veneering of a camel VHH in framework-2 to mimic a VH.
    Conrath K; Vincke C; Stijlemans B; Schymkowitz J; Decanniere K; Wyns L; Muyldermans S; Loris R
    J Mol Biol; 2005 Jul; 350(1):112-25. PubMed ID: 15913651
    [TBL] [Abstract][Full Text] [Related]  

  • 86. High affinity anti-Internalin B VHH antibody fragments isolated from naturally and artificially immunized repertoires.
    Gene RW; Kumaran J; Aroche C; van Faassen H; Hall JC; MacKenzie CR; Arbabi-Ghahroudi M
    J Immunol Methods; 2015 Jan; 416():29-39. PubMed ID: 25450000
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice.
    Abe M; Yuki Y; Kurokawa S; Mejima M; Kuroda M; Park EJ; Scheller J; Nakanishi U; Kiyono H
    J Biotechnol; 2014 Apr; 175():45-52. PubMed ID: 24548461
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Allosteric inhibition of VIM metallo-β-lactamases by a camelid nanobody.
    Sohier JS; Laurent C; Chevigné A; Pardon E; Srinivasan V; Wernery U; Lassaux P; Steyaert J; Galleni M
    Biochem J; 2013 Mar; 450(3):477-86. PubMed ID: 23289540
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Transgenic Heavy Chain IgG Mouse Platform as a Source of High Affinity Fully Human Single-Domain Antibodies for Therapeutic Applications.
    Drabek D; Janssens R; van Haperen R; Grosveld F
    Methods Mol Biol; 2022; 2446():121-141. PubMed ID: 35157271
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Monoclonal antibodies for the identification and purification of vNAR domains and IgNAR immunoglobulins from the horn shark Heterodontus francisci.
    Juarez K; Dubberke G; Lugo P; Koch-Nolte F; Buck F; Haag F; Licea A
    Hybridoma (Larchmt); 2011 Aug; 30(4):323-9. PubMed ID: 21851231
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Generation of a phage-display library of single-domain camelid VH H antibodies directed against Chlamydomonas reinhardtii antigens, and characterization of VH Hs binding cell-surface antigens.
    Jiang W; Rosenberg JN; Wauchope AD; Tremblay JM; Shoemaker CB; Weeks DP; Oyler GA
    Plant J; 2013 Nov; 76(4):709-17. PubMed ID: 23980604
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.
    Wang Y; Fan Z; Shao L; Kong X; Hou X; Tian D; Sun Y; Xiao Y; Yu L
    Int J Nanomedicine; 2016; 11():3287-303. PubMed ID: 27499623
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Evaluation of the Potential Impact of In Silico Humanization on V
    Martins C; Diharce J; Nadaradjane AA; de Brevern AG
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834033
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Nanoantibodies: small molecules, big possibilities.
    Pedreáñez A; Mosquera-Sulbarán J; Muñóz N; Tene D; Robalino J
    BioTechnologia (Pozn); 2021; 102(3):321-336. PubMed ID: 36606147
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intramolecular trimerization, a novel strategy for making multispecific antibodies with controlled orientation of the antigen binding domains.
    Alvarez-Cienfuegos A; Nuñez-Prado N; Compte M; Cuesta AM; Blanco-Toribio A; Harwood SL; Villate M; Merino N; Bonet J; Navarro R; Muñoz-Briones C; Sørensen KM; Mølgaard K; Oliva B; Sanz L; Blanco FJ; Alvarez-Vallina L
    Sci Rep; 2016 Jun; 6():28643. PubMed ID: 27345490
    [TBL] [Abstract][Full Text] [Related]  

  • 96. VHH antibodies: emerging reagents for the analysis of environmental chemicals.
    Bever CS; Dong JX; Vasylieva N; Barnych B; Cui Y; Xu ZL; Hammock BD; Gee SJ
    Anal Bioanal Chem; 2016 Sep; 408(22):5985-6002. PubMed ID: 27209591
    [TBL] [Abstract][Full Text] [Related]  

  • 97. High-level expression of Camelid nanobodies in Nicotiana benthamiana.
    Teh YH; Kavanagh TA
    Transgenic Res; 2010 Aug; 19(4):575-86. PubMed ID: 19862637
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.
    Hu Y; Liu C; Muyldermans S
    Front Immunol; 2017; 8():1442. PubMed ID: 29163515
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Cell-free Expression Pipeline for the Generation and Functional Characterization of Nanobodies.
    Haueis L; Stech M; Kubick S
    Front Bioeng Biotechnol; 2022; 10():896763. PubMed ID: 35573250
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Single domain antibodies from camelids in the treatment of microbial infections.
    De Greve H; Fioravanti A
    Front Immunol; 2024; 15():1334829. PubMed ID: 38827746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.